Granahan Investment Management LLC Trims Stake in Stoke Therapeutics, Inc. (NASDAQ:STOK)
MarketBeat
Granahan Investment Management LLC cut its stake in Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) by 12.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 567,689 shares of the company's stock after selling 77,281
NASDAQ:STOK